Impact of beta2-agonists, beta-blockers, and their combination on cardiac function in elderly male patients with chronic obstructive pulmonary disease

References

• RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med200717653255517507545
   PubMed Web of Science ®Google Scholar
• HardieJAVollmerWMBuistASBakkePMørkveORespiratory symptoms and obstructive pulmonary disease in a population aged over 70 yearsRespir Med20059918619515715185
   PubMed Web of Science ®Google Scholar
• HalbertRJNatoliJLGanoABadamgaravEBuistASManninoDMGlobal burden of COPD: systematic review and meta-analysisEur Respir J20062852353216611654
   PubMed Web of Science ®Google Scholar
• KitzmanDWGardinJMGottdienerJSImportance of heart failure with preserved systolic function in patients ≥65 years of age. CHS Research Group. Cardiovascular Health StudyAm J Cardiol20018741341911179524
   PubMed Web of Science ®Google Scholar
• IversenKKKjaergaardJAkkanDChronic obstructive pulmonary disease in patients admitted with heart failureJ Intern Med200826436136918537871
   PubMed Web of Science ®Google Scholar
• Le JemtelTHPadelettiMJelicSDiagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failureJ Am Coll Cardiol20074917118017222727
   PubMed Web of Science ®Google Scholar
• BraunsteinJBAndersonGFGerstenblithGNoncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failureJ Am Coll Cardiol2003421226312314522486
   PubMed Web of Science ®Google Scholar
• HawkinsNMHuangZPieperKSChronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)Eur J Heart Fail20091129229819176539
   PubMed Web of Science ®Google Scholar
• HawkinsNMPetrieMCJhundPSChalmersGWDunnFGMcMurrayJJHeart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiologyEur J Heart Fail20091113013919168510
   PubMed Web of Science ®Google Scholar
• BerminghamMO’CallaghanEDawkinsIAre beta2-agonists responsible for increased mortality in heart failure?Eur J Heart Fail20111388589121791542
   PubMed Web of Science ®Google Scholar
• NewtonGEAzevedoERParkerJDInotropic and sympathetic responses to the intracoronary infusion of a beta2-receptor agonist: a human in vivo studyCirculation1999992402240710318661
   PubMed Web of Science ®Google Scholar
• Wood-BakerRCochraneBNaughtonMTCardiovascular mortality and morbidity in chronic obstructive pulmonary disease: the impact of bronchodilator treatmentIntern Med J2010409410119849745
   PubMed Web of Science ®Google Scholar
• AuDHUdrisEMFanVSCurtisJRMcDonellMBFihnSDRisk of mortality and heart failure exacerbations associated with inhaled β-adrenoceptor agonists among patients with known left ventricular systolic dysfunctionChest20031231964196912796175
   PubMed Web of Science ®Google Scholar
• BristowMRGilbertEMAbrahamWTCarvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure: MOCHA investigatorsCirculation199694280728168941106
   PubMed Web of Science ®Google Scholar
• DicksteinKCohen-SolalAFilippatosGESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)Eur Heart J2008292388244218799522
   PubMed Web of Science ®Google Scholar
• SalpeterSOrmistonTSalpeterECardioselective beta-blockers for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20054CD00356616235327
   PubMed Web of Science ®Google Scholar
• JabbourAMacdonaldPSKeoghAMDifferences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trialJ Am Coll Cardiol2010551780178720413026
   PubMed Web of Science ®Google Scholar
• HawkinsNMJhundPSSimpsonCRPrimary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in ScotlandEur J Heart Fail201012172419951962
   PubMed Web of Science ®Google Scholar
• SalisburyACReidKJSpertusJAImpact of chronic obstructive pulmonary disease on post-myocardial infarction outcomesAm J Cardiol20079963664117317363
   PubMed Web of Science ®Google Scholar
• van der WoudeHJZaagsmaJPostmaDSWinterTHvan HulstMAalbersRDetrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockersChest200512781882415764762
   PubMed Web of Science ®Google Scholar
• EgredMShawSMohammadBWaittPRodriguesEUnder-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary diseaseQJM20059849349715955798
   PubMed Web of Science ®Google Scholar
• World Medical AssociationWorld Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects Available from: http://www.wma.net/en/30publications/10policies/b3/index.htmlAccessed October 29, 2012
   Google Scholar
• HawkinsNMWangDPetrieMCBaseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programmeEur J Heart Fail20101255756520356870
   PubMed Web of Science ®Google Scholar
• Choucair-JaafarNBeetzNGilsbachRCardiovascular effects of chronic treatment with a beta2-adrenoceptor agonist relieving neuropathic pain in miceNeuropharmacology201161516021352833
   PubMed Web of Science ®Google Scholar
• NgTMMungerMALombardiWLChronically inhaled salmeterol improves pulmonary function in heart failureJ Cardiovasc Pharmacol20024014014512072587
   PubMed Web of Science ®Google Scholar
• RosenbergJGustafssonFRemmeWJRieggerGAHildebrandtPREffect of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failureCardiovasc Drugs Ther20082230531118309461
   PubMed Web of Science ®Google Scholar
• ShahzamaniMGhanavatiAFroutaghehANCarvedilol compared with metoprolol on left ventricular ejection fraction after coronary artery bypass graftJ Perianesth Nurs20112638438722099130
   PubMed Web of Science ®Google Scholar
• AuDHBrysonCLFanVSBeta-blockers as single-agent therapy for hypertension and the risk of mortality among patients with chronic obstructive pulmonary diseaseAm J Med200411792593115629731
   PubMed Web of Science ®Google Scholar
• RuttenFHZuithoffNPHakEGrobbeeDEHoesAWBeta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary diseaseArch Intern Med201017088088720498416
   PubMed Web of Science ®Google Scholar
• BristowMRGinsburgRUmansVBeta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failureCirc Res1986592973092876788
   PubMed Web of Science ®Google Scholar
• PerssonBAnderssonOKHjemdahlPWysockiMAgerwallSWallinGAdrenaline infusion in man increases muscle sympathetic nerve activity and noradrenaline overflow to plasmaJ Hypertens198977477562551959
   PubMed Web of Science ®Google Scholar
• ArnoldJMMcDevittDGHeart rate and blood pressure responses to intravenous boluses of isoprenaline in the presence of propranolol, practolol and atropineBr J Clin Pharmacol1983161751846137231
   PubMed Web of Science ®Google Scholar
• StraussMHReevesRASmithDLLeenanFHHThe role of cardiac β1-receptors in the hemodynamic response to a β2-agonistClin Pharmacol Ther1986401081153013487
   PubMed Web of Science ®Google Scholar
• LevineMALeenenFHRole of beta 1-receptors and vagal tone in cardiac inotropic and chronotropic responses to a beta 2-agonist in humansCirculation1989791071152562936
   PubMed Web of Science ®Google Scholar
• SchäfersRFAdlerSDaulAPositive inotropic effects of the β2-adrenoceptor agonist terbutaline in the failing human heart: effects of long-term β1-adrenoceptor antagonist treatmentJ Am Coll Cardiol199423122412338144793
   PubMed Web of Science ®Google Scholar
• BettencourtPAzevedoAPimentaJFriõesFFerreiraSFerreiraAN-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patientsCirculation20041102168217415451800
   PubMed Web of Science ®Google Scholar
• KragelundCGrønningBKøberLHildebrandtPSteffensenRN-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart diseaseN Engl J Med200535266667515716560
   PubMed Web of Science ®Google Scholar
• ZhangYBunjhooHXiongWXuYYangDAssociation between C-reactive protein concentration and chronic obstructive pulmonary disease: a systematic review and meta-analysisJ Int Med Res2012401629163523206444
   PubMed Web of Science ®Google Scholar